Cargando…

Changing the Paradigm of Cancer Screening, Prevention, and Treatment

The war on cancer has been fought during the past several decades primarily based on the somatic mutation model of cancer. This has resulted in the emphasis on cancer screening and elimination of any detected cancerous/precancerous cells as the primary method of cancer prevention. This approach has...

Descripción completa

Detalles Bibliográficos
Autor principal: Doss, Mohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134297/
https://www.ncbi.nlm.nih.gov/pubmed/27928220
http://dx.doi.org/10.1177/1559325816680539
_version_ 1782471439486550016
author Doss, Mohan
author_facet Doss, Mohan
author_sort Doss, Mohan
collection PubMed
description The war on cancer has been fought during the past several decades primarily based on the somatic mutation model of cancer. This has resulted in the emphasis on cancer screening and elimination of any detected cancerous/precancerous cells as the primary method of cancer prevention. This approach has reduced mortality from some cancers, but age-adjusted cancer mortality rates continue to be high. The lack of significant progress in reducing cancer mortality rates may be indicative of a fundamental flaw in the cancer model used. An alternative model of cancer is the immune suppression model of cancer based on the tremendous increase in cancers when the immune system is suppressed. According to this model, the key carcinogenic event is the suppression of the immune system which enables the already existing covert cancers to grow uncontrollably, causing cancer. Hence, cancer screening would consist of identifying those with weak immune system response. The primary mode of cancer prevention and treatment would be boosting of the immune system, for example, through exercise, infection, and low-dose radiation, as they are all known to enhance immune system response and reduce cancers. There is sufficient evidence to justify clinical trials of this approach for cancer screening, prevention, and treatment.
format Online
Article
Text
id pubmed-5134297
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-51342972016-12-07 Changing the Paradigm of Cancer Screening, Prevention, and Treatment Doss, Mohan Dose Response Invited Review The war on cancer has been fought during the past several decades primarily based on the somatic mutation model of cancer. This has resulted in the emphasis on cancer screening and elimination of any detected cancerous/precancerous cells as the primary method of cancer prevention. This approach has reduced mortality from some cancers, but age-adjusted cancer mortality rates continue to be high. The lack of significant progress in reducing cancer mortality rates may be indicative of a fundamental flaw in the cancer model used. An alternative model of cancer is the immune suppression model of cancer based on the tremendous increase in cancers when the immune system is suppressed. According to this model, the key carcinogenic event is the suppression of the immune system which enables the already existing covert cancers to grow uncontrollably, causing cancer. Hence, cancer screening would consist of identifying those with weak immune system response. The primary mode of cancer prevention and treatment would be boosting of the immune system, for example, through exercise, infection, and low-dose radiation, as they are all known to enhance immune system response and reduce cancers. There is sufficient evidence to justify clinical trials of this approach for cancer screening, prevention, and treatment. SAGE Publications 2016-11-30 /pmc/articles/PMC5134297/ /pubmed/27928220 http://dx.doi.org/10.1177/1559325816680539 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Invited Review
Doss, Mohan
Changing the Paradigm of Cancer Screening, Prevention, and Treatment
title Changing the Paradigm of Cancer Screening, Prevention, and Treatment
title_full Changing the Paradigm of Cancer Screening, Prevention, and Treatment
title_fullStr Changing the Paradigm of Cancer Screening, Prevention, and Treatment
title_full_unstemmed Changing the Paradigm of Cancer Screening, Prevention, and Treatment
title_short Changing the Paradigm of Cancer Screening, Prevention, and Treatment
title_sort changing the paradigm of cancer screening, prevention, and treatment
topic Invited Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134297/
https://www.ncbi.nlm.nih.gov/pubmed/27928220
http://dx.doi.org/10.1177/1559325816680539
work_keys_str_mv AT dossmohan changingtheparadigmofcancerscreeningpreventionandtreatment